Drug Shortage Report for AURO-PREGABALIN
Report ID | 111592 |
Drug Identification Number | 02433885 |
Brand name | AURO-PREGABALIN |
Common or Proper name | Pregabalin |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 75MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-04-08 |
Estimated end date | |
Actual end date | 2020-09-03 |
Shortage status | Resolved |
Updated date | 2020-09-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2020-09-04 | French | Compare |
v11 | 2020-09-04 | English | Compare |
v10 | 2020-08-14 | French | Compare |
v9 | 2020-08-14 | English | Compare |
v8 | 2020-07-27 | French | Compare |
v7 | 2020-07-27 | English | Compare |
v6 | 2020-06-08 | French | Compare |
v5 | 2020-06-08 | English | Compare |
v4 | 2020-05-25 | French | Compare |
v3 | 2020-05-25 | English | Compare |
v2 | 2020-04-09 | French | Compare |
v1 | 2020-04-09 | English | Compare |
Showing 1 to 12 of 12